Featured
Gene therapy effective in hemophilia B patients with neutralizing antibodies
All three patients have had sustained increases in factor IX activity at 1 year of follow-up.
Latest News
February 22, 2020
Apalutamide benefit sustained in mCSPC regardless of next therapy
February 22, 2020
Genitourinary Cancers Symposium
MDedge Hematology and Oncology
February 22, 2020
Seminoma: Risk-adapted strategy could mean less toxic chemo
February 22, 2020
Genitourinary Cancers Symposium
MDedge Hematology and Oncology
February 22, 2020
Tumor neoantigenicity metric improves prediction of response to immunotherapy
February 22, 2020
MDedge Hematology and Oncology
B&C Podcast Shownotes
Treatment tips in CLL
The million-dollar question in the treatment of CLL is what to do after a patient relapses following treatment with venetoclax. Dr. Anthony Mato, Dr. Lindsey Roeker, and Dr. David H. Henry discuss. In Clinical Correlation, Dr. Ilana Yurkiewicz talks about patient compliance and how clinician biases can influence it.
Opinion
February 13, 2020
Asymptomatic, erythematous papules on the neck
February 13, 2020
MDedge Hematology and Oncology
Conference Coverage
February 22, 2020
Apalutamide benefit sustained in mCSPC regardless of next therapy
February 22, 2020
Genitourinary Cancers Symposium
MDedge Hematology and Oncology
February 22, 2020
Seminoma: Risk-adapted strategy could mean less toxic chemo
February 22, 2020
Genitourinary Cancers Symposium
MDedge Hematology and Oncology
February 21, 2020
SBRT may boost efficacy of immunotherapy in renal cell carcinoma
February 21, 2020
Genitourinary Cancers Symposium
MDedge Hematology and Oncology
Drug Approvals
February 13, 2020
Lorcaserin withdrawn from U.S. market due to cancer risk
February 13, 2020
MDedge Hematology and Oncology
February 5, 2020
FDA issues public health warning recommending against cesium salt usage
February 5, 2020
MDedge Hematology and Oncology
January 24, 2020
FDA approves first treatment for advanced epithelioid sarcoma
January 24, 2020
MDedge Hematology and Oncology
Policy & Practice
February 19, 2020
‘Momentous’ USMLE change: New pass/fail format stuns medicine
February 19, 2020
MDedge Hematology and Oncology
February 18, 2020
Private equity firms acquiring more physician group practices
February 18, 2020
MDedge Hematology and Oncology
February 12, 2020
Trump seeks to cut NIH, CDC budgets, some Medicare spending
February 12, 2020
MDedge Hematology and Oncology
February 10, 2020
What you absolutely need to know about tail coverage
February 10, 2020
MDedge Hematology and Oncology
February 10, 2020
Cancer research foundation awards ‘breakthrough scientists’
February 10, 2020
MDedge Hematology and Oncology
February 7, 2020
CMS proposes second specialty tier for Medicare drugs
February 7, 2020
MDedge Hematology and Oncology
February 7, 2020
Funding failures: Tobacco prevention and cessation
February 7, 2020
MDedge Hematology and Oncology